Höfundar: Berglind Eva Benediktsdóttir

Engineered extracellular vesicles from a HEK293 cell line as a potential nanosized drug delivery system to tackle specific cancer subtypes

Notkun teymisnáms (e. Team-based learning, TBL) í lyfjafræði og upplifun nemenda af því

Scroll to Top

Á þessu vefsvæði eru notaðar vafrakökur.